Status:

UNKNOWN

Gut Microbiota and Alzheimer's Diseases

Lead Sponsor:

Shanghai 10th People's Hospital

Conditions:

Alzheimer Disease

Eligibility:

All Genders

60+ years

Brief Summary

The investigator will perform clinical studies to test a hypothesis that participants who have Alzheimer's disease will have different gut/oral microbiota profile as compared to the participants who d...

Detailed Description

Studies have shown that gut/oral microbiome and beta-amyloid in body may have a significant impact on the behavior and brain pathology consistent with Alzheimer's disease (AD) neuropathogenesis. The o...

Eligibility Criteria

Inclusion

  • aged 60 and older

Exclusion

  • with other acute gastrointestinal diseases
  • with other severe neuropsychiatric disorders

Key Trial Info

Start Date :

February 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT03827733

Start Date

February 1 2018

End Date

December 31 2022

Last Update

April 19 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Tenth People's Hospital

Shanghai, Shanghai Municipality, China, 200072